📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial. (2018)

First Author: Deakin B

Attributed to: AMBROSIAC - A Menu for Brain Responses Opposing Stress-Induced Alterations in Cognition funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2215-0366(18)30345-6

PubMed Identifier: 30322824

Publication URI: http://europepmc.org/abstract/MED/30322824

Type: Journal Article/Review

Volume: 5

Parent Publication: The lancet. Psychiatry

Issue: 11

ISSN: 2215-0366